Allied Market Research

2026

Rare Disease Genetic Testing Market

Rare Disease Genetic Testing Market (2023-2032)

by Disease (Neurological Disorders, Immunological Disorders, Hematology Diseases, Endocrine Metabolism Diseases, Cancer Musculoskeletal Disorders, Cardiovascular Disorders (CVDs), Dermatology Disease, Others), by Technology (Next-Generation Sequencing (NGS), Array Technology, PCR-based Testing, FISH, Sanger Sequencing, Karyotyping) and, by End-Users (Research Laboratories and CROs, Diagnostic Laboratories, Hospitals and Clinics)

LS : Diagnostics and Biotech

Select an option
Author's: | Eswara Prasad
Publish Date: